Biblio

Author Title [ Type

] Year

Filters: Author is Uzay, Ant [Clear All Filters]

Journal Article

Safran EEsma, Mutluay F, Uzay A. Effects of neuromuscular electrical stimulation combined with resistance exercises on muscle strength in adult hematological cancer patients: A randomized controlled study. Leuk Res. 2022;121:106932.

Erdemoglu Y, Aydingoz IEsen, Ustun C, Uzay A, Besli Y, Durmaz EOzturk, Demirkesen C, Sahin S. Fusariosis manifesting as targetoid purpuric cutaneous lesions in immunocompromised patients. J Eur Acad Dermatol Venereol. 2020.

Atesoglu EBirtas, Gulbas Z, Uzay A, Ozcan M, Özkalemkaş F, Dal MSinan, Kalyon H, Akay OMeltem, Deveci B, Bekoz H, et al. Glofitamab in relapsed/refractory diffuse large B-cell lymphoma: Real-world data. Hematol Oncol. 2023.

Dal MSinan, Ulu BUncu, Uzay A, Akay OMeltem, Beşışık S, Yenerel MNuri, Çelik S, Kaynar L, Yucel OKemal, Deveci B, et al. Polatuzumab vedotin, rituximab, and bendamustine combination in relapsed or refractory diffuse large B-cell lymphoma: a real-world data from Turkey. Ann Hematol. 2022.

Zeiser R, Polverelli N, Ram R, Hashmi SK, Chakraverty R, Middeke JMoritz, Musso M, Giebel S, Uzay A, Langmuir P, et al. Ruxolitinib for Glucocorticoid-Refractory Chronic Graft-versus-Host Disease. N Engl J Med. 2021;385(3):228-238.

Uzay A, Gündoğdu Y, Koşan B, Yetiş T, S Kartı S. Treosulfan is a safe and effective alternative to busulfan for conditioning in adult allogeneic HSCT patients: Data from a single center. Cancer Med. 2024;13(10):e7292.